KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $489,000 | -32.0% | 46,472 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $719,000 | +90.2% | 46,472 | +79.4% | 0.01% | +75.0% |
| Q3 2020 | $378,000 | -23.0% | 25,900 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $491,000 | -1.4% | 25,900 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $498,000 | +39.1% | 25,900 | +38.5% | 0.01% | +75.0% |
| Q4 2019 | $358,000 | +98.9% | 18,700 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $180,000 | +60.7% | 18,700 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $112,000 | +2.8% | 18,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $109,000 | -37.7% | 18,700 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $175,000 | -45.0% | 18,700 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $318,000 | 0.0% | 18,700 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |